167 related articles for article (PubMed ID: 22701616)
21. Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
Ren M; Cowell JK
Blood; 2011 Jun; 117(25):6837-47. PubMed ID: 21527531
[TBL] [Abstract][Full Text] [Related]
22. A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors.
Rolink A; ten Boekel E; Melchers F; Fearon DT; Krop I; Andersson J
J Exp Med; 1996 Jan; 183(1):187-94. PubMed ID: 8551222
[TBL] [Abstract][Full Text] [Related]
23. Early recovery of circulating immature B cells in B-lymphoblastic leukemia patients after CD19 targeted CAR T cell therapy: A pitfall for minimal residual disease detection.
Xiao W; Salem D; McCoy CS; Lee D; Shah NN; Stetler-Stevenson M; Yuan CM
Cytometry B Clin Cytom; 2018 May; 94(3):434-443. PubMed ID: 28888074
[TBL] [Abstract][Full Text] [Related]
24. The SH2 domain of bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype.
Zhang X; Wong R; Hao SX; Pear WS; Ren R
Blood; 2001 Jan; 97(1):277-87. PubMed ID: 11133772
[TBL] [Abstract][Full Text] [Related]
25. Myeloid/lymphoid neoplasm with eosinophilia and BCR/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report.
Isaza AP; Quintero SC; González LPQ; Córdoba FEA; Olivar AFA; Ocaña JCB
J Med Case Rep; 2023 Jan; 17(1):39. PubMed ID: 36698221
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-3 and interleukin-7 are alternative growth factors for the same B-cell precursors in the mouse.
Winkler TH; Melchers F; Rolink AG
Blood; 1995 Apr; 85(8):2045-51. PubMed ID: 7536488
[TBL] [Abstract][Full Text] [Related]
27. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice.
Million RP; Aster J; Gilliland DG; Van Etten RA
Blood; 2002 Jun; 99(12):4568-77. PubMed ID: 12036890
[TBL] [Abstract][Full Text] [Related]
28. Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice.
Hu T; Chong Y; Lu S; Qin H; Ren M; Savage NM; Chang CS; Cowell JK
Cancer Res; 2019 Jan; 79(1):114-124. PubMed ID: 30413411
[TBL] [Abstract][Full Text] [Related]
29. [Clinical pathological features of the 8p11 myeloproliferative syndrome].
Yan Z; Yang B; Wang QS; Wang LL; Han XP; Ren F; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1321-6. PubMed ID: 21129285
[TBL] [Abstract][Full Text] [Related]
30. miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the
Hu T; Chong Y; Lu S; Wang R; Qin H; Silva J; Kitamura E; Chang CS; Hawthorn L; Cowell JK
Cancer Res; 2018 Jul; 78(13):3522-3531. PubMed ID: 29735550
[TBL] [Abstract][Full Text] [Related]
31. FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model.
Grundler R; Miething C; Thiede C; Peschel C; Duyster J
Blood; 2005 Jun; 105(12):4792-9. PubMed ID: 15718420
[TBL] [Abstract][Full Text] [Related]
32. Distinct progenitors for B-1 and B-2 cells are present in adult mouse spleen.
Ghosn EE; Sadate-Ngatchou P; Yang Y; Herzenberg LA; Herzenberg LA
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2879-84. PubMed ID: 21282663
[TBL] [Abstract][Full Text] [Related]
33. Identification of CD19(-)B220(+)c-Kit(+)Flt3/Flk-2(+)cells as early B lymphoid precursors before pre-B-I cells in juvenile mouse bone marrow.
Ogawa M; ten Boekel E; Melchers F
Int Immunol; 2000 Mar; 12(3):313-24. PubMed ID: 10700466
[TBL] [Abstract][Full Text] [Related]
34. Normal cellular prion protein is preferentially expressed on subpopulations of murine hemopoietic cells.
Liu T; Li R; Wong BS; Liu D; Pan T; Petersen RB; Gambetti P; Sy MS
J Immunol; 2001 Mar; 166(6):3733-42. PubMed ID: 11238614
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies inhibit interleukin-7-mediated proliferation and are associated with the age-dependent loss of pre-B cells in autoimmune New Zealand Black Mice.
Merchant MS; Garvy BA; Riley RL
Blood; 1996 Apr; 87(8):3289-96. PubMed ID: 8605345
[TBL] [Abstract][Full Text] [Related]
36. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
[TBL] [Abstract][Full Text] [Related]
37. NK cells in the CD19- B220+ bone marrow fraction are increased in senescence and reduce E2A and surrogate light chain proteins in B cell precursors.
King AM; Keating P; Prabhu A; Blomberg BB; Riley RL
Mech Ageing Dev; 2009 Jun; 130(6):384-92. PubMed ID: 19428458
[TBL] [Abstract][Full Text] [Related]
38. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
Uckun FM; Haissig S; Ledbetter JA; Fidler P; Myers DE; Kuebelbeck V; Weisdorf D; Gajl-Peczalska K; Kersey JH; Ramsay NK
Blood; 1992 Jun; 79(12):3369-79. PubMed ID: 1375851
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice.
Chen Y; Hu Y; Michaels S; Segal D; Brown D; Li S
Leukemia; 2009 Aug; 23(8):1446-54. PubMed ID: 19322212
[TBL] [Abstract][Full Text] [Related]
40. A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene.
Yamamoto K; Kawano H; Nishikawa S; Yakushijin K; Okamura A; Matsui T
Eur J Haematol; 2006 Oct; 77(4):349-54. PubMed ID: 16879608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
